Journal article
Review: Azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn disease
Authors
Marshall JK
Journal
Annals of Internal Medicine, Vol. 148, No. 12, pp. jc4–jc9
Publisher
American College of Physicians
Publication Date
June 2008
DOI
10.7326/0003-4819-148-12-200806170-02009
ISSN
1056-8751